Transplantation
(Hepatology. 2005;41:1-26)
REFERRAL:
Decision ultimately rests with the transplant center
Transplant when the natural history of liver disease suggest a better survival with transplant
United Network for Organ Sharing (www.UNOS.org): develops minimum criteria for listing
INDICATIONS:
Acute liver failure/Fulminant hepatic failure (7%): These patients are assigned the highest priority (called Status 1)
ESLD: Cirrhosis with liver failure (80%); Those with Child-Pugh ≥7 (B) or MELD ≥10-15 should be considered for transplant
Congenital:
Hemochromatosis, Wilson’s, α1-AT, Cystic fibrosis, Congenital hepatic fibrosis, Oxylosis, Hereditary/Familial amyloidosis
Hepatic Tumor (10%):
Hepatocellular carcinoma (HCC): can be associated with: HBV, HCV, Heriditary Hemochromatosis, NASH with Cirrhosis
Milian Criteria (represent those acceptable to transplant): 1 tumor <5 cm, 2 or 3 tumors <3 cm; No metastasis
Hepatic adenoma, Carcinoid tumor
Other: Recurrent or severe encephalopathy, Refractory ascites, SBP, Recurrent variceal bleeding
Hepatorenal syndrome
Bilirubin >10 mg/dl, Albumin <3 g/dl, PT >3 sec above control
CONTRAINDICATIONS:
Absolute:
Uncontrolled sepsis/infection, Active ETOH/Substance abuse, Extrahepatic malignancy, Inadequate social support
Hepatocellular carcinoma (see Milian criteria, above); Extensive portal and/or mesenteric vein thrombosis
Severe comorbidities: advanced cardiac disease (CAD, CHF, Cor pulmonale), Advanced HIV/AIDS
Relative (depends on severity of conditions and experience of center)
Cholangiocarcinoma, Pulmonary hypertension (uncontrolled), Previous extensive abdominal surgery, Advance age (?)
Thrombosis: Portal vein, Hepatic artery; HIV/AIDS infection
EVALUATION/SCORING: The sickest first …
Child-Turcotte-Pugh class (A: 5-6, B: 7-9, C: 10-15); See also Liver- Cirrhosis & Encephalopathy (Chapter 4.08)
Generally those B or C are considered for transplant
Used to stratify patients on liver transplant list; Removes subjectivity of physician bias
Continuous measurement of disease activity; Independent of complications of PHTN such as varices, SBP
Based on Cr, INR & total bilirubin to predict 3 month survival in patients with a variety of underlying forms of liver disease
Will probably incorporate the use of sodium (and hence indirectly, ascites) in the future (Gastroenterology. 2006;130:1652-1660)
Calculate: Yahoo/Google search ‘MELD score’ for free online calculators
Mayo MELD Score = 11.2 In (INR) + 3.78 In (Bilirubin) + 9.57 In (Cr) + 6.43 (rounded to nearest integer)Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree